Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel

C. P. Smith, Ian; D. Heys, Steven; W. Hutcheon, Andrew; D. Miller, Iain; Payne, Simon; J. Gilbert, Fiona; K. Ah-See, Antoinne; Eremin, Oleg; G. Walker, Leslie; K. Sarkar, Tarun; Peter Eggleton, S.; N. Ogston, Keith

doi:10.1200/jco.2002.20.6.1456

Public

Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel

Published in Journal of Clinical Oncology • Mar 15, 2002

Authors:

Ian C. P. Smith

Steven D. Heys

Andrew W. Hutcheon

Abstract

PURPOSE: To compare the efficacy of neoadjuvant (NA) docetaxel (DOC) with anthracycline-based therapy and determine the efficacy of NA DOC in patients with breast cancer initially failing to respond to anthracycline-based NA chemotherapy (CT). PATIENTS AND METHODS: Patients with large or locally adv...

Subject

Medicine

Docetaxel

Cyclophosphamide

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!